Mitochondria in cancer: in the aspects of tumorigenesis and targeted therapy

被引:83
|
作者
Badrinath, Narayanasamy [1 ,2 ]
Yoo, So Young [2 ,3 ]
机构
[1] Pusan Natl Univ, Sch Med, Biomed Sci, Yangsan 50612, South Korea
[2] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan 50612, South Korea
[3] Pusan Natl Univ, BIO IT Foundry Technol Inst, Busan 46241, South Korea
基金
新加坡国家研究基金会;
关键词
CELL-DEATH PATHWAY; DNA MUTATIONS; COMPLEX-I; MICROSATELLITE INSTABILITY; COLORECTAL CARCINOMAS; HEXOKINASE-II; CYTOCHROME-C; GENOMIC INSTABILITY; AEROBIC GLYCOLYSIS; PYLORI INFECTION;
D O I
10.1093/carcin/bgy148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mitochondria play pivotal roles in most eukaryotic cells, ranging from energy production to regulation of apoptosis. As sites of cellular respiration, mitochondria experience accumulation of reactive oxygen species (ROS) due to damage in electron transport chain carriers. Mutations in mitochondrial DNA (mtDNA) as well as nuclear DNA are reported in various cancers. Mitochondria have a dual role in cancer: the development of tumors due to mutations in mitochondrial genome and the generation of ROS. Impairment in the mitochondria-regulated apoptosis pathway accelerates tumorigenesis. Numerous strategies targeting mitochondria have been developed to induce the mitochondrial (i.e. intrinsic) apoptosis pathway in cancer cells. This review elaborates the roles of mitochondria in cancer with respect to mutations and apoptosis and discusses mitochondria-targeting strategies as cancer therapies to enhance the killing of cancer cells.
引用
收藏
页码:1419 / 1430
页数:12
相关论文
共 50 条
  • [41] Mitochondria: integrators in tumorigenesis?
    Augenlicht, LH
    Heerdt, BG
    NATURE GENETICS, 2001, 28 (02) : 104 - 105
  • [42] Antisense molecules for targeted cancer therapy. Scientific aspects and clinical perspectives
    Zangemeister-Wittke, U.
    ONKOLOGE, 2007, 13 (03): : 256 - +
  • [43] Mitochondria-targeted compounds in the treatment of cancer
    Kafkova, A.
    Trnka, J.
    NEOPLASMA, 2020, 67 (03) : 450 - 460
  • [44] Mitochondria-targeted radiocomplexes for cancer theranostics
    Fernandes, Celia
    Santos, Joana
    Braz, Maria
    Silva, Francisco
    Raposinho, Paula
    Guerreiro, Joana
    Cleeren, Frederik
    Cassells, Irwin
    Mendes, Filipa
    Paulo, Antonio
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S51 - S52
  • [45] Mitochondria Targeted AIE Probes for Cancer Phototherapy
    Ingle, Jaypalsing
    Basu, Sudipta
    ACS OMEGA, 2023, 8 (10): : 8925 - 8935
  • [46] RICTOR Affects Melanoma Tumorigenesis and Its Resistance to Targeted Therapy
    Jebali, Ahlem
    Battistella, Maxime
    Lebbe, Celeste
    Dumaz, Nicolas
    BIOMEDICINES, 2021, 9 (10)
  • [47] Oncometabolites-driven tumorigenesis: From genetics to targeted therapy
    Morin, Aurelie
    Letouze, Eric
    Gimenez-Roqueplo, Anne-Paule
    Favier, Judith
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (10) : 2237 - 2248
  • [48] A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
    Shibata, Masahiro
    Ham, Kendall
    Hoque, Mohammad Obaidul
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (09) : 2133 - 2144
  • [49] Advances with microRNAs in Tumorigenesis and Cancer Therapy
    Wang, Zhiwei
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (33) : 5245 - 5245
  • [50] Anaplastic thyroid cancer, tumorigenesis and therapy
    J. P. O’Neill
    D. Power
    C. Condron
    D. Bouchier-Hayes
    M. Walsh
    Irish Journal of Medical Science, 2010, 179 : 9 - 15